Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cortech Reports Three and Nine Months Results.


BEDMINSTER Bedminster may refer to:
  • Bedminster, Bristol, United Kingdom
  • Bedminster Down, Bristol, United Kingdom
  • Bedminster Township, New Jersey, United States
  • Bedminster Township, Pennsylvania, United States
, N.J.--(BUSINESS WIRE)--Nov. 16, 1999--

CORTECH, INC inc - /ink/ increment, i.e. increase by one. Especially used by assembly programmers, as many assembly languages have an "inc" mnemonic.

Antonym: dec.
. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
 - "CRTQ") reported net income for the three months ended September September: see month.  30, 1999 of $263,000, or $.14 per share, compared to a net loss of $1,281,000, or $.69 per share, for the comparable period in 1998. For the nine months ended September 30, 1999, net income was $2,305,000, or $1.24 per share, compared to a net loss of $4,111,000, or $2.22 per share, for the comparable period in the prior year. Net income for nine months ended September 30, 1999 includes a non-recurring license fee of $2,000,000 received in connection with an agreement with Ono Ono (ō`nō), in the Bible, town, W central ancient Palestine, the modern Qiryat Ono, Israel, E of Tel Aviv.  Pharmaceutical Co., Ltd of Osaka Osaka (ō`säkä), city (1990 pop. 2,623,801), capital of Osaka prefecture, S Honshu, Japan, on Osaka Bay, at the mouth of the Yodo River. , Japan, to license the worldwide rights to an oral elastase elastase /elas·tase/ (e-las´tas) see pancreatic elastase.

e·las·tase
n.
An enzyme found especially in pancreatic juice that catalyzes the hydrolysis of elastin.
 inhibitor inhibitor /in·hib·i·tor/ (in-hib´i-tor)
1. any substance that interferes with a chemical reaction, growth, or other biologic activity.

2.
 program. Cortech continues to investigate opportunities to redeploy re·de·ploy  
tr.v. re·de·ployed, re·de·ploy·ing, re·de·ploys
1. To move (military forces) from one combat zone to another.

2.
 its assets into an operating business. Per share information referred to in this news release is both basic and diluted earnings per share diluted earnings per share

An earnings measure calculated by dividing net income less preferred stock dividends for a period by the average number of shares of common stock that would be outstanding if all convertible securities were converted into shares of
. Cortech has 1,852,209 shares outstanding.

This release contains forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 which may involve known and unknown risks, uncertainties and other factors that may cause Cortech's actual results and performance in future periods to be materially different from any future results or performance suggested by these statements. Cortech cautions investors not to place undue reliance on forward-looking statements, which speak only to management's expectations on this date.
                            CORTECH, INC.
                           OPERATING RESULTS
                  FOR THE THREE AND NINE MONTHS ENDED
                      SEPTEMBER 30, 1999 AND 1998
                 (in thousands, except per share data)
                              (Unaudited)

                             Three Months Ended   Nine Months Ended
                                  September 30,       September 30,
                                 1999      1998      1999      1998

Revenues:

 Interest income              $   157   $   171   $   408   $   550
 Gain on disposition of
  property and equipment          125        --       435       228
 Non-recurring license fee         --        --     2,000        --
 Other income                      92        --       152        22
                               ------    ------    ------    ------
     Total revenues               374       171     2,995       800
                               ------    ------    ------    ------

Expenses:

 General and administrative       101     1,452       462     4,475
 Research and development          --        --        --       436
                               ------    ------    ------    ------
     Total expenses               101     1,452       462     4,911
                               ------    ------    ------    ------

Income (loss) before income
 taxes                            273   ( 1,281)    2,533   ( 4,111)
Provision for income taxes         10        --       228        --
                               ------    ------    ------    ------
Net income (loss)             $   263   ($1,281)  $ 2,305   ($4,111)
                               ======    ======    ======    ======
Basic and diluted net income
 (loss) per common share      $   .14   ($  .69)  $  1.24   ($ 2.22)
                               ======    ======    ======    ======
Weighted average number
 of common shares outstanding   1,852     1,852     1,852     1,852
                               ======    ======    ======    ======


                        CONDENSED BALANCE SHEET
                          September 30, 1999
                            (in thousands)
                              (Unaudited)

Cash and cash equivalents                         $13,446
Prepaid expenses and other                              9
                                                  -------
     Total assets                                 $13,455
                                                  =======

Liabilities                                       $   609
Stockholders' equity                               12,846
                                                  -------
     Total liability and  stockholders' equity    $13,455
                                                  =======
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 16, 1999
Words:419
Previous Article:Forbes Congratulates Novartis on Aviva Market Launch in Select European Countries.
Next Article:Auction of History-Making Mallory & Irvine Research Expedition Equipment to Benefit Himalayan Charities.
Topics:



Related Articles
Cortech Makes Announcement.
Cortech, Inc. Reports Financial Results.
Cortech, Inc. Announces Operating Results.
CORTECH Announces Second Quarter Results.
CORTECH Announces Third Quarter Results.
Cortech, Inc. Makes Announcement.
Cortech Announces Second Quarter Results.
Cortech Announces Third Quarter Results.
FIRM'S FISCAL REPORT ANYTHING BUT GOLDEN.
Cortech Announces First Quarter Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles